Foresite Capital Management V, LLC Theseus Pharmaceuticals, Inc. Transaction History

Foresite Capital Management V, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.66 - $10.04 $1.39 Million - $5.26 Million	523,450 Added 14.6%	4,108,796 $11.1 Million
Q4 2022 Feb 13, 2023	BUY	$4.69 - $8.36 $1.17 Million - $2.09 Million	250,000 Added 7.5%	3,585,346 $17.9 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $14.05 $617,974 - $1.72 Million	122,614 Added 3.82%	3,335,346 $18.4 Million
Q4 2021 Feb 11, 2022	BUY	$8.98 - $20.09 $28.9 Million - $64.5 Million	3,212,732 New	3,212,732 $40.7 Million

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management V, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management V, LLC with notifications on news.